AzTrials
AzTrials

Scheuermann's KyphosisNCT05953792

Selecting the SSV-1 as LIV in Scheuermann's Kyphosis

An observational study of Scheuermann's Kyphosis, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proper selection of the lowest instrumented vertebra (LIV) remains controversial in the surgical treatment of Scheuermann's disease and there is a paucity of studies investigating the clinical outcomes of fusion surgery when selecting the vertebra one level proximal to the sagittal stable vertebra (SSV-1) as LIV. Read more about this study

Who is it for?
Ages 10 to 20 years
Conditions the study is for
Scheuermann's Kyphosis
What is being tested?
Select the vertebra above sagittal stable vertebra as the distal fusion level
Type of treatment
Surgery or procedure
How many people
74 participants
Where
1 siteChina
Study dates
1 Jan 2018to 31 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 20 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: A total of 36 SK patients (including 23 with TK and 13 patients with TLK) were included in this study, among which 29 were male, and 7 were female.

Who may be able to join

  • diagnosis of SK patients;
  • underwent one-stage posterior spinal fusion (PSF) with multi-level Ponte osteotomies;
  • selecting SSV-1 as LIV;
  • with a minimum follow-up of 2 years.

Who cannot join

  • with previous spinal surgical history;
  • with any other spinal deformities;
  • without complete follow-up data.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Drum Tower Hospital of Nanjing University Medical School

    Nanjing, Jiangsu, 210000

Other trials in China

About this study

Official title: Selecting the Vertebra Above Sagittal Stable Vertebra as the Distal Fusion Level in Scheuermann's Kyphosis

The proper selection of the lowest instrumented vertebra (LIV) remains controversial in the surgical treatment of Scheuermann's disease and there is a paucity of studies investigating the clinical outcomes of fusion surgery when selecting the vertebra one level proximal to the sagittal stable vertebra (SSV-1) as LIV. The purpose of this study is to investigate whether SSV-1 could be a valid LIV for Scheuermann kyphosis (SK) patients with different curve patterns.

Read the detailed description

The proper selection of the lowest instrumented vertebra (LIV) remains controversial in the surgical treatment of Scheuermann's disease and there is a paucity of studies investigating the clinical outcomes of fusion surgery when selecting the vertebra one level proximal to the sagittal stable vertebra (SSV-1) as LIV. The purpose of this study is to investigate whether SSV-1 could be a valid LIV for Scheuermann kyphosis (SK) patients with different curve patterns.

This was a prospective study on consecutive SK patients treated with posterior surgery between January 2018 and September 2020, in which the distal fusion level ended at SSV-1. The LIV was selected at SSV-1 only in patients with Risser > 2 and with LIV translation less than 40mm. All of the patients had a minimum of 2-year follow-up. Patients were further grouped based on the sagittal curve pattern as thoracic kyphosis (TK) and thoracolumbar kyphosis (TLK). Radiographic parameters including global kyphosis (GK), lumbar lordosis (LL), sagittal vertical axis (SVA), LIV translation, pelvic incidence (PI), pelvic tilt (PT), sacral slope (SS) were measured preoperatively, postoperatively and at the latest follow-up. The intraoperative and postoperative complications were recorded. The Scoliosis Research Society (SRS)-22 scores were performed to evaluate clinical outcomes.

Being tested
Select the vertebra above sagittal stable vertebra as the distal fusion level
Medical subject headings
Scheuermann Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Select the vertebra above sagittal stable vertebra as the distal fusion levelProcedure or surgery

    The surgeries were performed by the same surgical team. Multi-level Ponte osteotomies were performed across the apex of the kyphosis after complete exposure of the spine, with resection of supra- and inter-spinous ligaments, ligamentum flavum, and the whole facet joints. After placement of the pedicle screws at the expected fusion levels, pre-contoured rods were attached to the screws followed by segmental compression. During rod placement, two to three rounds of compression in the area with Ponte osteotomies were employed to enhance kyphosis correction. Satellite rods were routinely added to long rods and implanted with duet screws. The final tightening was performed, and the posterior fusion was completed with a mixture of local and allogeneic bone. Due attention was given to preserving the posterior ligamentous structures at the upper and lower junctional areas.

Study groups in NCT05953792
Study groupRoleWhat they receive
thoracic kyphosispatients with their kyphotic apex located at T10 or above
Receives: Procedure: Select the vertebra above sagittal stable vertebra as the distal fusion level
thoracolumbar kyphosispatients with their kyphotic apex located below T10
Receives: Procedure: Select the vertebra above sagittal stable vertebra as the distal fusion level

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Global kyphosis (GK) in degrees

    Measured on anteroposterior and lateral radiographs and defined as the angle from upper to lower most tilted end vertebrae.

    Measured: 24 months

  2. Lumbar lordosis (LL) in degrees

    Measured on anteroposterior and lateral radiographs and defined as the angle between the the superior end plate of L1 and S1

    Measured: 24 months

  3. Sagittal vertical axis (SVA) in millimeters

    Measured on anteroposterior and lateral radiographs and defined as the horizontal distance between C7PL and the posterior superior corner of sacrum.

    Measured: 24 months

Secondary outcomes (2)
  1. Rates of distal junctional kyphosis

    record the incidence of the distal junctional kyphosis at the last follow-up. Distal junctional kyphosis was defined as a distal junctional angle ≥10˚, or a distal junctional angle ≥ 10˚ than the preoperative measurement

    Measured: 24 months

  2. Scoliosis Research Society (SRS)-22 questionnaire

    The Scoliosis Research Society (SRS)-22 questionnaire is adopted to assess the patient-reported outcomes. The overall score can range from 22 to 110 points, and higher scores reflect better health status.

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2023
  2. Study start1 Jan 2018
  3. Primary completion30 Sep 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05953792
Sponsor's protocol ID
2021-LCYJ-DBZ-05
Status last verified
Jul 2023
First submitted
2 Jul 2023
Last updated
20 Jul 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Scheuermann's Kyphosis, run by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Global kyphosis (GK) in degrees (time frame: 24 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in